Keyphrases
Myocardial Blood Flow
85%
Coronary Microvascular Dysfunction
70%
Obesity
66%
Vasodilation
66%
Epicardial
66%
Positron Emission Tomography-computed Tomography (PET-CT)
60%
Morbid Obesity
56%
Body Mass Index
50%
Hyperemia
49%
Cardiometabolic Risk
46%
U-turn
41%
Coronary Microvascular Function
40%
Circulatory Function
37%
Normal Weight
36%
Normal Coronary Arteries
36%
Incremental Cost
33%
Prognostic Value
33%
Dipyridamole
33%
Percutaneous Coronary Intervention
33%
Acute Myocardial Infarction
33%
Older Patients
33%
United States
33%
CT Examination
33%
Heart Disease
33%
Thallium
33%
Acute Kidney Injury
33%
Functional Impairment
33%
Structural Impairment
33%
Flow Gradient
25%
13N-ammonia PET
20%
Metabolic Syndrome
20%
Inducible Ischemia
16%
Arrhythmia
16%
Congestive Heart Failure
16%
Reinfarction
16%
Valvular
16%
Acute Coronary Artery Syndrome
16%
Syncope
16%
Risk Factors
16%
Hospital Discharge
16%
Dyslipidemia
16%
Cardiology General
16%
High Blood Pressure
16%
Cardiovascular Risk
13%
Classical Type
13%
Symptomatic Patients
13%
Beta-blockers
11%
Aspirin
11%
Recurrent Myocardial Infarction
11%
Disease Entity
10%
Medicine and Dentistry
Heart Muscle Blood Flow
88%
Coronary Microvascular Dysfunction
71%
Vasodilatation
66%
Body Mass Index
61%
Positron Emission Tomography-Computed Tomography
60%
Prevalence
46%
Cardiometabolic Risk
46%
Morbid Obesity
43%
Heart Disease
33%
Polyethylene Terephthalate
33%
Ammonia N 13
31%
Obesity
27%
Hyperaemia
22%
Metabolic Syndrome
20%
Hypertension
20%
Faintness
16%
Cardiology
16%
Cardiac Dysrhythmia
16%
Congestive Heart Failure
16%
Coronary Artery
16%
Dyslipidemia
16%
Population Research
14%
Cardiovascular Risk
13%
Coronary Artery Calcification
13%
Body Weight
11%
Heart Muscle Perfusion
10%
Coronary Circulation
10%
Vasomotion
9%
Analysis of Variance
6%
Adipose Tissue
6%
Diseases
6%
Scoring System
6%
Pharmacology, Toxicology and Pharmaceutical Science
Polyethylene Terephthalate
100%
Morbid Obesity
58%
Ammonia N 13
54%
Obesity
47%
Acute Kidney Failure
33%
Cardiovascular Risk
33%
Prevalence
33%
Acute Heart Infarction
33%
Dipyridamole
33%
Population Study
29%
Hyperaemia
26%
Ischemia
20%
Diseases
16%
Heart Infarction
13%
Beta Adrenergic Receptor Blocking Agent
13%
Acetylsalicylic Acid
13%
Clinical Study
8%
Diabetes Mellitus
8%
Combination Therapy
8%
Bradycardia
8%
Hypertension
8%
Metabolic Syndrome X
8%
Heart Left Ventricle Failure
6%
Prospective Cohort Study
6%